open
serve
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
News
Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News
Ask Genius
Apps
IJR News — today's news from every side
Ask Genius
Apps
Trending
NeuroThera advances enrollment in SCI-210 autism trial toward 60-participant goal
x/soroka-medical-center
— 1d
NeuroThera Labs’ SCI-210, a CBD-CannAmide formulation for autism, is advancing in a double-blind trial at Soroka Medical Center in Israel, with enrollment moving toward 60 participants and early momentum reported (six in Article 1, 26 by mid-trial updates in Articles 2 and 3) and endpoints including the ABC-C and CGI-I assessments. The program, conducted under NeuroThera as a SciSparc subsidiary, aims to determine whether SCI-210 offers advantages over CBD alone, with plans to commercialize initially in Israel if successful.
+3
Share
Israeli Hostage Rescued From Gaza Tunnel In Complex Operation
Reporting
— Sep 4, 2024
Qaid Farhan al-Qadi with his brother at Soroka Medical Center following his rescue from Gaza. COURTESY “> Israel Defense Forces troops on Tuesday rescued an Israeli hostage Qaid Farhan al-Qadi from an underground tunnel…
Share
